KSHV genome replication and maintenance

Frontiers in Microbiology

Volumn 7, Issue FEB, 2016, Pages

  Purushothaman, Pravinkumar ^a   Dabral, Prerna ^a   Gupta, Namrata ^a   Sarkar, Roni ^a   Verma, Subhash C ^a  

^a UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

Author keywords

KSHV; LANA; Latency; LBS; Ori A; Ori P; Pre RC; Replication

Indexed keywords

CASPASE 8; HYPOXIA INDUCIBLE FACTOR; JANUS KINASE; KAPOSIN; LATENCY ASSOCIATED NUCLEAR ANTIGEN; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE P38; NOTCH RECEPTOR; STAT PROTEIN; UNCLASSIFIED DRUG; VCYCLIN; VIRUS PROTEIN;

DNA REPLICATION; EPISOME; GENOME ANALYSIS; HUMAN HERPESVIRUS 8; INTRACELLULAR SIGNALING; LATENT VIRUS INFECTION; NONHUMAN; NUCLEOSOME; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; VIRUS CELL INTERACTION; VIRUS GENOME; VIRUS REPLICATION; WNT SIGNALING PATHWAY;

EID: 84962097624     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2016.00054     Document Type: Review

References (190)

1. Adam, Z., Szturz, P., Koukalová, R., Rehák, Z., Pour, L., Krejcí, M., et al. (2015). [PET-CT documented remission of multicentric Castleman disease after treatment with rituximab: case report and review]. Vnitr. Lek. 61, 251-259.
2. Alexiadis, V., Waldmann, T., Andersen, J., Mann, M., Knippers, R., and Gruss, C. (2000). The protein encoded by the proto-oncogene DEK changes the topology of chromatin and reduces the efficiency of DNA replication in a chromatin-specific manner. Genes Dev. 14, 1308-1312. doi: 10.1101/gad.14.11.1308
3. Angelova, M., Ferris, M., Swan, K. F., McFerrin, H. E., Pridjian, G., Morris, C. A., et al. (2014). Kaposi's sarcoma-associated herpesvirus G-protein coupled receptor activates the canonical Wnt/beta-catenin signaling pathway. Virol. J. 11, 218. doi: 10.1186/s12985-014-0218-8
4. Aravind, L., and Landsman, D. (1998). AT-hook motifs identified in a wide variety of DNA-binding proteins. Nucleic Acids Res. 26, 4413-4421. doi: 10.1093/nar/26.19.4413
5. Artavanis-Tsakonas, S., Rand, M. D., and Lake, R. J. (1999). Notch signaling: cell fate control and signal integration in development. Science 284, 770-776. doi: 10.1126/science.284.5415.770
6. Ballestas, M. E., Chatis, P. A., and Kaye, K. M. (1999). Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. Science 284, 641-644. doi: 10.1126/science.284.5414.641
7. Ballestas, M. E., and Kaye, K. M. (2001). Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mediates episome persistence through cis-acting terminal repeat (TR) sequence and specifically binds TR DNA. J. Virol. 75, 3250-3258. doi: 10.1128/JVI.75.7.3250-3258.2001
8. Ballestas, M. E., and Kaye, K. M. (2011). The latency-associated nuclear antigen, a multifunctional protein central to Kaposi's sarcoma-associated herpesvirus latency. Future Microbiol. 6, 1399-1413. doi: 10.2217/fmb.11.137
9. Barbera, A. J., Chodaparambil, J. V., Kelley-Clarke, B., Joukov, V., Walter, J. C., Luger, K., et al. (2006). The nucleosomal surface as a docking station for Kaposi's sarcoma herpesvirus LANA. Science 311, 856-861. doi: 10.1126/science.1120541
10. Boss, I. W., Plaisance, K. B., and Renne, R. (2009). Role of virus-encoded microRNAs in herpesvirus biology. Trends Microbiol. 17, 544-553. doi: 10.1016/j.tim.2009.09.002
11. Burger, M., Hartmann, T., Burger, J. A., and Schraufstatter, I. (2005). KSHV-GPCR and CXCR2 transforming capacity and angiogenic responses are mediated through a JAK2-STAT3-dependent pathway. Oncogene 24, 2067-2075. doi: 10.1038/sj.onc.1208442
12. Burỳsek, L., and Pitha, P. M. (2001). Latently expressed human herpesvirus 8-encoded interferon regulatory factor 2 inhibits double-stranded RNA-activated protein kinase. J. Virol. 75, 2345-2352. doi: 10.1128/JVI.75.5.2345-2352.2001
13. Cai, Q., Cai, S., Zhu, C., Verma, S. C., Choi, J. Y., and Robertson, E. S. (2013). A unique SUMO-2-interacting motif within LANA is essential for KSHV latency. PLoS Pathog. 9:e1003750. doi: 10.1371/journal.ppat.1003750
14. Cai, Q., Lan, K., Verma, S. C., Si, H., Lin, D., and Robertson, E. S. (2006). Kaposi's sarcoma-associated herpesvirus latent protein LANA interacts with HIF-1 alpha to upregulate RTA expression during hypoxia: latency control under low oxygen conditions. J. Virol. 80, 7965-7975. doi: 10.1128/JVI.00689-06
15. Cai, Q., Murakami, M., Si, H., and Robertson, E. S. (2007). A potential alpha-helix motif in the amino terminus of LANA encoded by Kaposi's sarcoma-associated herpesvirus is critical for nuclear accumulation of HIF-1alpha in normoxia. J. Virol. 81, 10413-10423. doi: 10.1128/JVI.00611-07
16. Cai, Q., Verma, S. C., Choi, J. Y., Ma, M., and Robertson, E. S. (2010a). Kaposi's sarcoma-associated herpesvirus inhibits interleukin-4-mediated STAT6 phosphorylation to regulate apoptosis and maintain latency. J. Virol. 84, 11134-11144. doi: 10.1128/JVI.01293-10
17. Cai, Q., Verma, S. C., Lu, J., and Robertson, E. S. (2010b). Molecular biology of Kaposi's sarcoma-associated herpesvirus and related oncogenesis. Adv. Virus Res. 78, 87-142. doi: 10.1016/B978-0-12-385032-4.00003-3
18. Campos, E. I., and Reinberg, D. (2009). Histones: annotating chromatin. Annu. Rev. Genet. 43, 559-599. doi: 10.1146/annurev.genet.032608.103928
19. Carroll, P. A., Kenerson, H. L., Yeung, R. S., and Lagunoff, M. (2006). Latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells activates hypoxia-induced factors. J. Virol. 80, 10802-10812. doi: 10.1128/JVI.00673-06
20. Cesarman, E. (2002). The role of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in lymphoproliferative diseases. Recent results in cancer research. Fortschritte der Krebsforschung. Progr. Dans Rech. Sur Cancer 159, 27-37. doi: 10.1007/978-3-642-56352-2_4
21. Cesarman, E., Chang, Y., Moore, P. S., Said, J. W., and Knowles, D. M. (1995). Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N. Engl. J. Med. 332, 1186-1191. doi: 10.1056/NEJM199505043321802
22. Chang, P. C., Fitzgerald, L. D., Van Geelen, A., Izumiya, Y., Ellison, T. J., Wang, D. H., et al. (2009). Kruppel-associated box domain-associated protein-1 as a latency regulator for Kaposi's sarcoma-associated herpesvirus and its modulation by the viral protein kinase. Cancer Res. 69, 5681-5689. doi: 10.1158/0008-5472.CAN-08-4570
23. Chang, P. C., and Kung, H. J. (2014). SUMO and KSHV Replication. Cancers 6, 1905-1924. doi: 10.3390/cancers6041905
24. Chang, Y., Cesarman, E., Pessin, M. S., Lee, F., Culpepper, J., Knowles, D. M., et al. (1994). Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266, 1865-1869. doi: 10.1126/science.7997879
25. Chen, J., Ueda, K., Sakakibara, S., Okuno, T., Parravicini, C., Corbellino, M., et al. (2001). Activation of latent Kaposi's sarcoma-associated herpesvirus by demethylation of the promoter of the lytic transactivator. Proc. Natl. Acad. Sci. U.S.A. 98, 4119-4124. doi: 10.1073/pnas.051004198
26. Cheng, F., Sawant, T. V., Lan, K., Lu, C., Jung, J. U., and Gao, S. J. (2015). Screening of the human kinome identifies MSK1/2-CREB1 as an Essential pathway mediating kaposi's sarcoma-associated herpesvirus lytic replication during primary infection. J. Virol. 89, 9262-9280. doi: 10.1128/JVI.01098-15
27. Collins, C. M., and Medveczky, P. G. (2002). Genetic requirements for the episomal maintenance of oncogenic herpesvirus genomes. Adv. Cancer Res. 84, 155-174. doi: 10.1016/S0065-230X(02)84005-2
28. Cotter, M. A. II, Robertson, E. S. (1999). The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells. Virology 264, 254-264. doi: 10.1006/viro.1999.9999
29. Cotter, M. A. II, Robertson, E. S. (2002). Molecular biology of Kaposi's sarcoma-associated herpesvirus. Front. Biosci. 7, d358-d375. doi: 10.2741/cotter
30. Curry, C. L., Reed, L. L., Broude, E., Golde, T. E., Miele, L., and Foreman, K. E. (2007). Notch inhibition in Kaposi's sarcoma tumor cells leads to mitotic catastrophe through nuclear factor-kappaB signaling. Mol. Cancer Ther. 6, 1983-1992. doi: 10.1158/1535-7163.MCT-07-0093
31. Curry, C. L., Reed, L. L., Golde, T. E., Miele, L., Nickoloff, B. J., and Foreman, K. E. (2005). Gamma secretase inhibitor blocks Notch activation and induces apoptosis in Kaposi's sarcoma tumor cells. Oncogene 24, 6333-6344. doi: 10.1038/sj.onc.1208783
32. Davis, D. A., Rinderknecht, A. S., Zoeteweij, J. P., Aoki, Y., Read-Connole, E. L., Tosato, G., et al. (2001). Hypoxia induces lytic replication of Kaposi sarcoma-associated herpesvirus. Blood 97, 3244-3250. doi: 10.1182/blood. V97.10.3244
33. Denis, G. V., Vaziri, C., Guo, N., and Faller, D. V. (2000). RING3 kinase transactivates promoters of cell cycle regulatory genes through E2F. Cell Growth Differ. 11, 417-424.
34. Dey, A., Chitsaz, F., Abbasi, A., Misteli, T., and Ozato, K. (2003). The double bromodomain protein Brd4 binds to acetylated chromatin during interphase and mitosis. Proc. Natl. Acad. Sci. U.S.A. 100, 8758-8763. doi: 10.1073/pnas.1433065100
35. Dheekollu, J., Chen, H. S., Kaye, K. M., and Lieberman, P. M. (2013). Timeless-dependent DNA replication-coupled recombination promotes Kaposi's Sarcoma-associated herpesvirus episome maintenance and terminal repeat stability. J. Virol. 87, 3699-3709. doi: 10.1128/JVI.02211-12
36. Dimitrova, D. S., and Gilbert, D. M. (1999). The spatial position and replication timing of chromosomal domains are both established in early G1 phase. Mol. Cell 4, 983-993. doi: 10.1016/S1097-2765(00)80227-0
37. Direkze, S., and Laman, H. (2004). Regulation of growth signalling and cell cycle by Kaposi's sarcoma-associated herpesvirus genes. Int. J. Exp. Pathol. 85, 305-319. doi: 10.1111/j.0959-9673.2004.00407.x
38. Dittmer, D., Lagunoff, M., Renne, R., Staskus, K., Haase, A., and Ganem, D. (1998). A cluster of latently expressed genes in Kaposi's sarcoma-associated herpesvirus. J. Virol. 72, 8309-8315.
39. Domsic, J. F., Chen, H. S., Lu, F., Marmorstein, R., and Lieberman, P. M. (2013). Molecular basis for oligomeric-DNA binding and episome maintenance by KSHV LANA. PLoS Pathog. 9:e1003672. doi: 10.1371/journal.ppat.1003672
40. Doxsey, S., Zimmerman, W., and Mikule, K. (2005). Centrosome control of the cell cycle. Trends Cell Biol. 15, 303-311. doi: 10.1016/j.tcb.2005.04.008
41. Duprez, R., Lacoste, V., Briere, J., Couppie, P., Frances, C., Sainte-Marie, D., et al. (2007). Evidence for a multiclonal origin of multicentric advanced lesions of Kaposi sarcoma. J. Natl. Cancer Inst. 99, 1086-1094. doi: 10.1093/jnci/djm045
42. Emuss, V., Lagos, D., Pizzey, A., Gratrix, F., Henderson, S. R., and Boshoff, C. (2009). KSHV manipulates Notch signaling by DLL4 and JAG1 to alter cell cycle genes in lymphatic endothelia. PLoS Pathog. 5:e1000616. doi: 10.1371/journal.ppat.1000616
43. Feldman, E. R., Kara, M., Coleman, C. B., Grau, K. R., Oko, L. M., Krueger, B. J., et al. (2014). Virus-encoded microRNAs facilitate gammaherpesvirus latency and pathogenesis in vivo. MBio 5, e00981-e00914. doi: 10.1128/mBio.00981-14
44. Ford, P. W., Bryan, B. A., Dyson, O. F., Weidner, D. A., Chintalgattu, V., and Akula, S. M. (2006). Raf/MEK/ERK signalling triggers reactivation of Kaposi's sarcoma-associated herpesvirus latency. J. Gen. Virol. 87, 1139-1144. doi: 10.1099/vir.0.81628-0
45. Friborg, J. Jr., Kong, W., Hottiger, M. O., and Nabel, G. J. (1999). p53 inhibition by the LANA protein of KSHV protects against cell death. Nature 402, 889-894.
46. Fujimuro, M., and Hayward, S. D. (2003). The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus manipulates the activity of glycogen synthase kinase-3beta. J. Virol. 77, 8019-8030. doi: 10.1128/JVI.77.14.8019-8030.2003
47. Fujimuro, M., and Hayward, S. D. (2004). Manipulation of glycogen-synthase kinase-3 activity in KSHV-associated cancers. J. Mol. Med. 82, 223-231. doi: 10.1007/s00109-003-0519-7
48. Fujimuro, M., Wu, F. Y., ApRhys, C., Kajumbula, H., Young, D. B., Hayward, G. S., et al. (2003). A novel viral mechanism for dysregulation of beta-catenin in Kaposi's sarcoma-associated herpesvirus latency. Nat. Med. 9, 300-306. doi: 10.1038/nm829
49. Gao, S. J., Zhang, Y. J., Deng, J. H., Rabkin, C. S., Flore, O., and Jenson, H. B. (1999). Molecular polymorphism of Kaposi's sarcoma-associated herpesvirus (Human herpesvirus 8) latent nuclear antigen: evidence for a large repertoire of viral genotypes and dual infection with different viral genotypes. J. Infect. Dis. 180, 1466-1476. doi: 10.1086/315098
50. Garber, A. C., Shu, M. A., Hu, J., and Renne, R. (2001). DNA binding and modulation of gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus. J. Virol. 75, 7882-7892. doi: 10.1128/JVI.75.17.7882-7892.2001
51. Gehmlich, K., Haren, L., and Merdes, A. (2004). Cyclin B degradation leads to NuMA release from dynein/dynactin and from spindle poles. EMBO Rep. 5, 97-103. doi: 10.1038/sj.embor.7400046
52. Gottwein, E., and Cullen, B. R. (2010). A human herpesvirus microRNA inhibits p21 expression and attenuates p21-mediated cell cycle arrest. J. Virol. 84, 5229-5237. doi: 10.1128/JVI.00202-10
53. Gradoville, L., Gerlach, J., Grogan, E., Shedd, D., Nikiforow, S., Metroka, C., et al. (2000). Kaposi's sarcoma-associated herpesvirus open reading frame 50/Rta protein activates the entire viral lytic cycle in the HH-B2 primary effusion lymphoma cell line. J. Virol. 74, 6207-6212. doi: 10.1128/JVI.74.13.6207-6212.2000
54. Griffiths, R., and Whitehouse, A. (2007). Herpesvirus saimiri episomal persistence is maintained via interaction between open reading frame 73 and the cellular chromosome-associated protein MeCP2. J. Virol. 81, 4021-4032. doi: 10.1128/JVI.02171-06
55. Grundhoff, A., and Ganem, D. (2003). The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus permits replication of terminal repeat-containing plasmids. J. Virol. 77, 2779-2783. doi: 10.1128/JVI.77.4.2779-2783.2003
56. Guasparri, I., Keller, S. A., and Cesarman, E. (2004). KSHV vFLIP is essential for the survival of infected lymphoma cells. J. Exp. Med. 199, 993-1003. doi: 10.1084/jem.20031467
57. Günther, T., and Grundhoff, A. (2010). The epigenetic landscape of latent Kaposi sarcoma-associated herpesvirus genomes. PLoS Pathog. 6:e1000935. doi: 10.1371/journal.ppat.1000935
58. Guse, A. C., Carroll, C. W., Moree, B., Fuller, C. J., and Straight, A. F. (2011). In vitro centromere and kinetochore assembly on defined chromatin templates. Nature 477, 354-358. doi: 10.1038/nature10379
59. Han, S. J., Hu, J., Pierce, B., Weng, Z., and Renne, R. (2010). Mutational analysis of the latency-associated nuclear antigen DNA-binding domain of Kaposi's sarcoma-associated herpesvirus reveals structural conservation among gammaherpesvirus origin-binding proteins. J. Gen. Virol. 91, 2203-2215. doi: 10.1099/vir.0.020958-0
60. Hansen, A., Henderson, S., Lagos, D., Nikitenko, L., Coulter, E., Roberts, S., et al. (2010). KSHV-encoded miRNAs target MAF to induce endothelial cell reprogramming. Genes Dev. 24, 195-205. doi: 10.1101/gad.553410
61. Hellert, J., Weidner-Glunde, M., Krausze, J., Lunsdorf, H., Ritter, C., Schulz, T. F., et al. (2015). The 3D structure of Kaposi sarcoma herpesvirus LANA C-terminal domain bound to DNA. Proc. Natl. Acad. Sci. U.S.A. 112, 6694-6699. doi: 10.1073/pnas.1421804112
62. Hodgson, J. J., and Blow, J. J. (2002). Replication licensing-defining the proliferative state? Trends Cell Biol. 12, 72-78. doi: 10.1016/S0962-8924(01)02203-6
63. Hu, J., Garber, A. C., and Renne, R. (2002). The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus supports latent DNA replication in dividing cells. J. Virol. 76, 11677-11687. doi: 10.1128/JVI.76.22.11677-11687.2002
64. Hu, J., and Renne, R. (2005). Characterization of the minimal replicator of Kaposi's sarcoma-associated herpesvirus latent origin. J. Virol. 79, 2637-2642. doi: 10.1128/JVI.79.4.2637-2642.2005
65. Huberman, J. A., and Riggs, A. D. (1966). Autoradiography of chro-mosomal DNA fibers from Chinese hamster cells. Proc. Natl. Acad. Sci. U.S.A. 55, 599-606. doi: 10.1073/pnas.55.3.599
66. Israël, A. (2010). The IKK complex, a central regulator of NF-kappaB activation. Cold Spring Harb. Perspect. Biol. 2:a000158. doi: 10.1101/cshperspect.a000158
67. Iyengar, S., and Farnham, P. J. (2011). KAP1 protein: an enigmatic master regulator of the genome. J. Biol. Chem. 286, 26267-26276. doi: 10.1074/jbc. R111.252569
68. Jenner, R. G., Albà, M. M., Boshoff, C., and Kellam, P. (2001). Kaposi's sarcoma-associated herpesvirus latent and lytic gene expression as revealed by DNA arrays. J. Virol. 75, 891-902. doi: 10.1128/JVI.75.2.891-902.2001
69. 2AX Phosphorylation Is Important for LANA-Mediated Kaposi's sarcoma-associated herpesvirus episome persistence. J. Virol. 87, 5255-5269. doi: 10.1128/JVI.03575-12
70. Kanno, T., Kanno, Y., Siegel, R. M., Jang, M. K., Lenardo, M. J., and Ozato, K. (2004). Selective recognition of acetylated histones by bromodomain proteins visualized in living cells. Mol. Cell 13, 33-43. doi: 10.1016/S1097-2765(03)00482-9
71. Katano, H., Sato, Y., Itoh, H., and Sata, T. (2001). Expression of human herpesvirus 8 (HHV-8)-encoded immediate early protein, open reading frame 50, in HHV-8-associated diseases. J. Hum. Virol. 4, 96-102.
72. Ke, Q., and Costa, M. (2006). Hypoxia-inducible factor-1 (HIF-1). Mol. Pharmacol. 70, 1469-1480. doi: 10.1124/mol.106.027029
73. Klochkov, D. B., Gavrilov, A. A., Vassetzky, Y. S., and Razin, S. V. (2009). Early replication timing of the chicken alpha-globin gene domain correlates with its open chromatin state in cells of different lineages. Genomics 93, 481-486. doi: 10.1016/j.ygeno.2009.01.001
74. Komatsu, T., Ballestas, M. E., Barbera, A. J., Kelley-Clarke, B., and Kaye, K. M. (2004). KSHV LANA1 binds DNA as an oligomer and residues N-terminal to the oligomerization domain are essential for DNA binding, replication, and episome persistence. Virology 319, 225-236. doi: 10.1016/j.virol.2003.11.002
75. Krithivas, A., Fujimuro, M., Weidner, M., Young, D. B., and Hayward, S. D. (2002). Protein interactions targeting the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus to cell chromosomes. J. Virol. 76, 11596-11604. doi: 10.1128/JVI.76.22.11596-11604.2002
76. Kusano, S., and Eizuru, Y. (2010). Human I-mfa domain proteins specifically interact with KSHV LANA and affect its regulation of Wnt signaling-dependent transcription. Biochem. Biophys. Res. Commun. 396, 608-613. doi: 10.1016/j.bbrc.2010.04.111
77. Lagos, D., Pollara, G., Henderson, S., Gratrix, F., Fabani, M., Milne, R. S., et al. (2010). miR-132 regulates antiviral innate immunity through suppression of the p300 transcriptional co-activator. Nat. Cell Biol. 12, 513-519. doi: 10.1038/ncb2054
78. Lai, E. C. (2004). Notch signaling: control of cell communication and cell fate. Development 131, 965-973. doi: 10.1242/dev.01074
79. Lan, K., Kuppers, D. A., and Robertson, E. S. (2005). Kaposi's sarcoma-associated herpesvirus reactivation is regulated by interaction of latency-associated nuclear antigen with recombination signal sequence-binding protein Jkappa, the major downstream effector of the Notch signaling pathway. J. Virol. 79, 3468-3478. doi: 10.1128/JVI.79.6.3468-3478.2005
80. Lan, K., Kuppers, D. A., Verma, S. C., and Robertson, E. S. (2004). Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virus-mediated control of latency. J. Virol. 78, 6585-6594. doi: 10.1128/JVI.78.12.6585-6594.2004
81. Lan, K., Verma, S. C., Murakami, M., Bajaj, B., Kaul, R., and Robertson, E. S. (2007). Kaposi's sarcoma herpesvirus-encoded latency-associated nuclear antigen stabilizes intracellular activated Notch by targeting the Sel10 protein. Proc. Natl. Acad. Sci. U.S.A. 104, 16287-16292. doi: 10.1073/pnas.0703508104
82. Lee, J. W., Bae, S. H., Jeong, J. W., Kim, S. H., and Kim, K. W. (2004). Hypoxia-inducible factor (HIF-1)alpha: its protein stability and biological functions. Exp. Mol. Med. 36, 1-12. doi: 10.1038/emm.2004.1
83. Lei, M. (2005). The MCM complex: its role in DNA replication and implications for cancer therapy. Curr. Cancer Drug Targets 5, 365-380. doi: 10.2174/1568009054629654
84. Lei, X., Bai, Z., Ye, F., Huang, Y., and Gao, S. J. (2010a). Regulation of herpesvirus lifecycle by viral microRNAs. Virulence 1, 433-435. doi: 10.4161/viru.1.5.12966
85. Lei, X., Bai, Z., Ye, F., Xie, J., Kim, C. G., Huang, Y., et al. (2010b). Regulation of NF-kappaB inhibitor IkappaBalpha and viral replication by a KSHV microRNA. Nat. Cell. Biol. 12, 193-199. doi: 10.1038/ncb2019
86. Li, Q., Zhou, F., Ye, F., and Gao, S. J. (2008). Genetic disruption of KSHV major latent nuclear antigen LANA enhances viral lytic transcriptional program. Virology 379, 234-244. doi: 10.1016/j.virol.2008.06.043
87. Li, S., Tan, M., Juillard, F., Ponnusamy, R., Correia, B., Simas, J. P., et al. (2015). The Kaposi's sarcoma herpesvirus latency-associated nuclear antigen DNA binding domain dorsal positive electrostatic patch facilitates DNA replication and episome persistence. J. Biol. Chem. 290, 28084-28096. doi: 10.1074/jbc. M115.674622
88. Liang, Y., Chang, J., Lynch, S. J., Lukac, D. M., and Ganem, D. (2002). The lytic switch protein of KSHV activates gene expression via functional interaction with RBP-Jkappa (CSL), the target of the Notch signaling pathway. Genes Dev. 16, 1977-1989. doi: 10.1101/gad.996502
89. Lim, C., Lee, D., Seo, T., Choi, C., and Choe, J. (2003). Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus functionally interacts with heterochromatin protein 1. J. Biol. Chem. 278, 7397-7405. doi: 10.1074/jbc. M211912200
90. Lim, C., Sohn, H., Gwack, Y., and Choe, J. (2000). Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) binds ATF4/CREB2 and inhibits its transcriptional activation activity. J. Gen. Virol. 81, 2645-2652. doi: 10.1099/0022-1317-81-11-2645
91. Lim, C., Sohn, H., Lee, D., Gwack, Y., and Choe, J. (2002). Functional dissection of latency-associated nuclear antigen 1 of Kaposi's sarcoma-associated herpesvirus involved in latent DNA replication and transcription of terminal repeats of the viral genome. J. Virol. 76, 10320-10331. doi: 10.1128/JVI.76.20.10320-10331.2002
92. Lin, Y. T., Kincaid, R. P., Arasappan, D., Dowd, S. E., Hunicke-Smith, S. P., and Sullivan, C. S. (2010). Small RNA profiling reveals antisense transcription throughout the KSHV genome and novel small RNAs. RNA 16, 1540-1558. doi: 10.1261/rna.1967910
93. Long, E., Ilie, M., Hofman, V., Havet, K., Selva, E., Butori, C., et al. (2009). LANA-1, Bcl-2, Mcl-1 and HIF-1alpha protein expression in HIV-associated Kaposi sarcoma. Virchows Archiv. 455, 159-170. doi: 10.1007/s00428-009-0791-1
94. Lu, F., Day, L., Gao, S. J., and Lieberman, P. M. (2006). Acetylation of the latency-associated nuclear antigen regulates repression of Kaposi's sarcoma-associated herpesvirus lytic transcription. J. Virol. 80, 5273-5282. doi: 10.1128/JVI.02541-05
95. Lu, F., Stedman, W., Yousef, M., Renne, R., and Lieberman, P. M. (2010). Epigenetic regulation of Kaposi's sarcoma-associated herpesvirus latency by virus-encoded microRNAs that target Rta and the cellular Rbl2-DNMT pathway. J. Virol. 84, 2697-2706. doi: 10.1128/JVI.01997-09
96. Lu, F., Zhou, J., Wiedmer, A., Madden, K., Yuan, Y., and Lieberman, P. M. (2003). Chromatin remodeling of the Kaposi's sarcoma-associated herpesvirus ORF50 promoter correlates with reactivation from latency. J. Virol. 77, 11425-11435. doi: 10.1128/JVI.77.21.11425-11435.2003
97. Luger, K., Mäder, A. W., Richmond, R. K., Sargent, D. F., and Richmond, T. J. (1997). Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature 389, 251-260. doi: 10.1038/38444
98. Marshall, V., Parks, T., Bagni, R., Wang, C. D., Samols, M. A., Hu, J., et al. (2007). Conservation of virally encoded microRNAs in Kaposi sarcoma-associated herpesvirus in primary effusion lymphoma cell lines and in patients with Kaposi sarcoma or multicentric Castleman disease. J. Infect. Dis. 195, 645-659. doi: 10.1086/511434
99. Matsumura, S., Persson, L. M., Wong, L., and Wilson, A. C. (2010). The latency-associated nuclear antigen interacts with MeCP2 and nucleosomes through separate domains. J. Virol. 84, 2318-2330. doi: 10.1128/JVI.01097-09
100. Mattsson, K., Kiss, C., Platt, G. M., Simpson, G. R., Kashuba, E., Klein, G., et al. (2002). Latent nuclear antigen of Kaposi's sarcoma herpesvirus/human herpesvirus-8 induces and relocates RING3 to nuclear heterochromatin regions. J. Gen. Virol. 83, 179-188. doi: 10.1099/0022-1317-83-1-179
101. Maxwell, P. H., Wiesener, M. S., Chang, G. W., Clifford, S. C., Vaux, E. C., Cockman, M. E., et al. (1999). The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399, 271-275. doi: 10.1038/20459
102. May, N. R., Thomer, M., and Murnen, K. F. Calvi, B. R. (2005). Levels of the origin-binding protein Double parked and its inhibitor Geminin increase in response to replication stress. J. Cell Sci. 118, 4207-4217. doi: 10.1242/jcs.02534
103. McClure, L. V., and Sullivan, C. S. (2008). Kaposi's sarcoma herpes virus taps into a host microRNA regulatory network. Cell Host Microbe 3, 1-3. doi: 10.1016/j.chom.2007.12.002
104. McCormick, C., and Ganem, D. (2005). The kaposin B protein of KSHV activates the p38/MK2 pathway and stabilizes cytokine mRNAs. Science 307, 739-741. doi: 10.1126/science.1105779
105. Meehan, R. R., Lewis, J. D., and Bird, A. P. (1992). Characterization of MeCP2, a vertebrate DNA binding protein with affinity for methylated DNA. Nucleic Acids Res. 20, 5085-5092. doi: 10.1093/nar/20.19.5085
106. Merdes, A., Ramyar, K., Vechio, J. D., and and Cleveland, D. W. (1996). A complex of NuMA and cytoplasmic dynein is essential for mitotic spindle assembly. Cell 87, 447-458. doi: 10.1016/S0092-8674(00)81365-3
107. Moldovan, G.-L., Pfander, B., and Jentsch, S. (2007). PCNA, the Maestro of the Replication Fork. Cell 129, 665-679. doi: 10.1016/j.cell.2007.05.003
108. Moore, P. S., and Chang, Y. (2010). Why do viruses cause cancer? Highlights of the first century of human tumour virology. Nat. Rev. Cancer 10, 878-889. doi: 10.1038/nrc2961
109. Morris, V. A., Punjabi, A. S., and Lagunoff, M. (2008). Activation of Akt through gp130 receptor signaling is required for Kaposi's sarcoma-associated herpesvirus-induced lymphatic reprogramming of endothelial cells. J. Virol. 82, 8771-8779. doi: 10.1128/JVI.00766-08
110. Muromoto, R., Okabe, K., Fujimuro, M., Sugiyama, K., Yokosawa, H., Seya, T., et al. (2006). Physical and functional interactions between STAT3 and Kaposi's sarcoma-associated herpesvirus-encoded LANA. FEBS Lett. 580, 93-98. doi: 10.1016/j.febslet.2005.11.057
111. Nan, X., Campoy, F. J., and Bird, A. (1997). MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell 88, 471-481. doi: 10.1016/S0092-8674(00)81887-5
112. Neipel, F., Albrecht, J. C., Ensser, A., Huang, Y. Q., Li, J. J., Friedman-Kien, A. E., et al. (1997). Human herpesvirus 8 encodes a homolog of interleukin-6. J. Virol. 71, 839-842.
113. Neipel, F., Albrecht, J. C., and Fleckenstein, B. (1998). Human herpesvirus 8-the first human Rhadinovirus. J. Natl. Cancer Inst. Monogr. 73-77. doi: 10.1093/oxfordjournals.jncimonographs.a024178
114. Nishitani, H., and Lygerou, Z. (2002). Control of DNA replication licensing in a cell cycle. Genes Cells. 7, 523-534. doi: 10.1046/j.1365-2443.2002.00544.x
115. Norio, P., and Schidkraut, C. L. (2001). Visualization of DNA replication on individual Epstein-Barr virus episomes. Science 294, 2361-2364. doi: 10.1126/science.1064603
116. Ohsaki, E., Suzuki, T., Karayama, M., and Ueda, K. (2009). Accumulation of LANA at nuclear matrix fraction is important for Kaposi's sarcoma-associated herpesvirus replication in latency. Virus Res. 139, 74-84. doi: 10.1016/j.virusres.2008.10.011
117. Ohsaki, E., and Ueda, K. (2012). Kaposi's sarcoma-associated herpesvirus genome replication, partitioning, and maintenance in latency. Front. Microbiol. 3:7. doi: 10.3389/fmicb.2012.00007
118. Ohsaki, E., Ueda, K., Sakakibara, S., Do, E., Yada, K., and Yamanishi, K. (2004). Poly(ADP-ribose) polymerase 1 binds to Kaposi's sarcoma-associated herpesvirus (KSHV) terminal repeat sequence and modulates KSHV replication in latency. J. Virol. 78, 9936-9946. doi: 10.1128/JVI.78.18.9936-9946.2004
119. Ottinger, M., Christalla, T., Nathan, K., Brinkmann, M. M., Viejo-Borbolla, A., and Schulz, T. F. (2006). Kaposi's sarcoma-associated herpesvirus LANA-1 interacts with the short variant of BRD4 and releases cells from a BRD4-and BRD2/RING3-induced G1 cell cycle arrest. J. Virol. 80, 10772-10786. doi: 10.1128/JVI.00804-06
120. Pamblanco, M., Poveda, A., Sendra, R., Rodríguez-Navarro, S., Pérez-Ortín, J. E., and Tordera, V. (2001). Bromodomain factor 1 (Bdf1) protein interacts with histones. FEBS Lett. 496, 31-35. doi: 10.1016/S0014-5793(01)02397-3
121. Pan, H., Xie, J., Ye, F., and Gao, S. J. (2006). Modulation of Kaposi's sarcoma-associated herpesvirus infection and replication by MEK/ERK, JNK, and p38 multiple mitogen-activated protein kinase pathways during primary infection. J. Virol. 80, 5371-5382. doi: 10.1128/JVI.02299-05
122. Pan, H., Zhou, F., and Gao, S. J. (2004). Kaposi's sarcoma-associated herpesvirus induction of chromosome instability in primary human endothelial cells. Cancer Res. 64, 4064-4068. doi: 10.1158/0008-5472.CAN-04-0657
123. Pantry, S. N., and Medveczky, P. G. (2009). Epigenetic regulation of Kaposi's sarcoma-associated herpesvirus replication. Semin. Cancer Biol. 19, 153-157. doi: 10.1016/j.semcancer.2009.02.010
124. Persson, L. M., and Wilson, A. C. (2010). Wide-scale use of Notch signaling factor CSL/RBP-Jkappa in RTA-mediated activation of Kaposi's sarcoma-associated herpesvirus lytic genes. J. Virol. 84, 1334-1347. doi: 10.1128/JVI.01301-09
125. Platt, G. M., Simpson, G. R., Mittnacht, S., and Schulz, T. F. (1999). Latent nuclear antigen of Kaposi's sarcoma-associated herpesvirus interacts with RING3, a homolog of the Drosophila female sterile homeotic (fsh) gene. J. Virol. 73, 9789-9795.
126. Ponnusamy, R., Petoukhov, M. V., Correia, B., Custodio, T. F., Juillard, F., Tan, M., et al. (2015). KSHV but not MHV-68 LANA induces a strong bend upon binding to terminal repeat viral DNA. Nucleic Acids Res. 43, 10039-10054. doi: 10.1093/nar/gkv987
127. Punj, V., Matta, H., Schamus, S., Tamewitz, A., Anyang, B., and Chaudhary, P. M. (2010). Kaposi's sarcoma-associated herpesvirus-encoded viral FLICE inhibitory protein (vFLIP) K13 suppresses CXCR4 expression by upregulating miR-146a. Oncogene 29, 1835-1844. doi: 10.1038/onc.2009.460
128. Punjabi, A. S., Carroll, P. A., Chen, L., and Lagunoff, M. (2007). Persistent activation of STAT3 by latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells. J. Virol. 81, 2449-2458. doi: 10.1128/JVI.01769-06
129. Purushothaman, P., McDowell, M. E., McGuinness, J., Salas, R., Rumjahn, S. M., and Verma, S. C. (2012). Kaposi's sarcoma-associated herpesvirus-encoded LANA recruits topoisomerase IIbeta for latent DNA replication of the terminal repeats. J. Virol. 86, 9983-9994. doi: 10.1128/JVI.00839-12
130. Qin, Z., DeFee, M., Isaacs, J. S., and Parsons, C. (2010a). Extracellular Hsp90 serves as a co-factor for MAPK activation and latent viral gene expression during de novo infection by KSHV. Virology 403, 92-102. doi: 10.1016/j.virol.2010.03.052
131. Qin, Z., Freitas, E., Sullivan, R., Mohan, S., Bacelieri, R., Branch, D., et al. (2010b). Upregulation of xCT by KSHV-encoded microRNAs facilitates KSHV dissemination and persistence in an environment of oxidative stress. PLoS Pathog. 6:e1000742. doi: 10.1371/journal.ppat.1000742
132. Radkov, S. A., Kellam, P., and Boshoff, C. (2000). The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells. Nat. Med. 6, 1121-1127. doi: 10.1038/80459
133. Rainbow, L., Platt, G. M., Simpson, G. R., Sarid, R., Gao, S. J., Stoiber, H., et al. (1997). The 222-to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen. J. Virol. 71, 5915-5921.
134. Ramalingam, D., Happel, C., and Ziegelbauer, J. M. (2015). Kaposi's sarcoma-associated herpesvirus microRNAs repress breakpoint cluster region protein expression, enhance Rac1 activity, and increase in vitro angiogenesis. J. Virol. 89, 4249-4261. doi: 10.1128/JVI.03687-14
135. Ravi, R., Mookerjee, B., Bhujwalla, Z. M., Sutter, C. H., Artemov, D., Zeng, Q., et al. (2000). Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha. Genes Dev. 14, 34-44. doi: 10.1101/gad.14.1.34
136. Renne, R., Lagunoff, M., Zhong, W., and Ganem, D. (1996). The size and conformation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in infected cells and virions. J. Virol. 70, 8151-8154.
137. Rossetto, C., Gao, Y., Yamboliev, I., Papouskova, I., and Pari, G. (2007). Transcriptional repression of K-Rta by Kaposi's sarcoma-associated herpesvirus K-bZIP is not required for oriLyt-dependent DNA replication. Virology 369, 340-350. doi: 10.1016/j.virol.2007.08.019
138. Roupelieva, M., Griffiths, S. J., Kremmer, E., Meisterernst, M., Viejo-Borbolla, A., Schulz, T., et al. (2010). Kaposi's sarcoma-associated herpesvirus Lana-1 is a major activator of the serum response element and mitogen-activated protein kinase pathways via interactions with the Mediator complex. J. Gen. Virol. 91, 1138-1149. doi: 10.1099/vir.0.017715-0
139. Russo, J. J., Bohenzky, R. A., Chien, M. C., Chen, J., Yan, M., Maddalena, D., et al. (1996). Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc. Natl. Acad. Sci. U.S.A. 93, 14862-14867. doi: 10.1073/pnas.93.25.14862
140. Sadagopan, S., Sharma-Walia, N., Veettil, M. V., Raghu, H., Sivakumar, R., Bottero, V., et al. (2007). Kaposi's sarcoma-associated herpesvirus induces sustained NF-kappaB activation during de novo infection of primary human dermal microvascular endothelial cells that is essential for viral gene expression. J. Virol. 81, 3949-3968. doi: 10.1128/JVI.02333-06
141. Sadler, R., Wu, L., Forghani, B., Renne, R., Zhong, W., Herndier, B., et al. (1999). A complex translational program generates multiple novel proteins from the latently expressed kaposin (K12) locus of Kaposi's sarcoma-associated herpesvirus. J. Virol. 73, 5722-5730.
142. Sarek, G., Järviluoma, A., Moore, H. M., Tojkander, S., Vartia, S., Biberfeld, P., et al. (2010). Nucleophosmin phosphorylation by v-cyclin-CDK6 controls KSHV latency. PLoS Pathog. 6:e1000818. doi: 10.1371/journal.ppat.1000818
143. Schwaiger, M., Kohler, H., Oakeley, E. J., Stadler, M. B., and Schubeler, D. (2010). Heterochromatin protein 1 (HP1) modulates replication timing of the Drosophila genome. Genome Res. 20, 771-780. doi: 10.1101/gr.101790.109
144. Seagroves, T. N., Ryan, H. E., Lu, H., Wouters, B. G., Knapp, M., Thibault, P., et al. (2001). Transcription factor HIF-1 is a necessary mediator of the pasteur effect in mammalian cells. Mol. Cell. Biol. 21, 3436-3444. doi: 10.1128/MCB.21.10.3436-3444.2001
145. Sharma-Walia, N., Krishnan, H. H., Naranatt, P. P., Zeng, L., Smith, M. S., and Chandran, B. (2005). ERK1/2 and MEK1/2 induced by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) early during infection of target cells are essential for expression of viral genes and for establishment of infection. J. Virol. 79, 10308-10329. doi: 10.1128/JVI.79.16.10308-10329.2005
146. Shaw, R. N., Arbiser, J. L., and Offermann, M. K. (2000). Valproic acid induces human herpesvirus 8 lytic gene expression in BCBL-1 cells. Aids 14, 899-902. doi: 10.1097/00002030-200005050-00021
147. Shin, Y. C., Joo, C. H., Gack, M. U., Lee, H. R., and Jung, J. U. (2008). Kaposi's sarcoma-associated herpesvirus viral IFN regulatory factor 3 stabilizes hypoxia-inducible factor-1 alpha to induce vascular endothelial growth factor expression. Cancer Res. 68, 1751-1759. doi: 10.1158/0008-5472.CAN-07-2766
148. Si, H., Verma, S. C., Lampson, M. A., Cai, Q., and Robertson, E. S. (2008). Kaposi's sarcoma-associated herpesvirus-encoded LANA can interact with the nuclear mitotic apparatus protein to regulate genome maintenance and segregation. J. Virol. 82, 6734-6746. doi: 10.1128/JVI.00342-08
149. Si, H., Verma, S. C., and Robertson, E. S. (2006). Proteomic analysis of the Kaposi's sarcoma-associated herpesvirus terminal repeat element binding proteins. J. Virol. 80, 9017-9030. doi: 10.1128/JVI.00297-06
150. Sodhi, A., Montaner, S., Patel, V., Zohar, M., Bais, C., Mesri, E. A., et al. (2000). The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1alpha. Cancer Res. 60, 4873-4880.
151. Staskus, K. A., Zhong, W., Gebhard, K., Herndier, B., Wang, H., Renne, R., et al. (1997). Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells. J. Virol. 71, 715-719.
152. Stedman, W., Deng, Z., Lu, F., and Lieberman, P. M. (2004). ORC, MCM, and histone hyperacetylation at the Kaposi's sarcoma-associated herpesvirus latent replication origin. J. Virol. 78, 12566-12575. doi: 10.1128/JVI.78.22.12566-12575.2004
153. Sun, Q., Tsurimoto, T., Juillard, F., Li, L., Li, S. E., et al. (2014b). Kaposi's sarcoma-associated herpesvirus LANA recruits the DNA polymerase clamp loader to mediate efficient replication and virus persistence. Proc. Natl. Acad. Sci. U.S.A. 111, 11816-11821. doi: 10.1073/pnas.1404219111
154. Sun, R., Liang, D., Gao, Y., and Lan, K. (2014a). Kaposi's sarcoma-associated herpesvirus-encoded LANA interacts with host KAP1 to facilitate establishment of viral latency. J. Virol. 88, 7331-7344. doi: 10.1128/JVI.00596-14
155. Sun, Z., Jha, H. C., and Robertson, E. S. (2015). Bub1 in Complex with LANA Recruits PCNA To Regulate Kaposi's Sarcoma-Associated Herpesvirus Latent Replication and DNA Translesion Synthesis. J. Virol. 89, 10206-10218. doi: 10.1128/JVI.01524-15
156. Tetsuka, T., Higuchi, M., Fukushi, M., Watanabe, A., Takizawa, S., Oie, M., et al. (2004). Visualization of a functional KSHV episome-maintenance protein LANA in living cells. Virus Genes 29, 175-182. doi: 10.1023/B:VIRU.0000036377.48454.d8
157. Toth, Z., Brulois, K., Lee, H. R., Izumiya, Y., Tepper, C., Kung, H. J., et al. (2013). Biphasic euchromatin-to-heterochromatin transition on the KSHV genome following de novo infection. PLoS Pathog. 9:e1003813. doi: 10.1371/journal.ppat.1003813
158. Toth, Z., Maglinte, D. T., Lee, S. H., Lee, H. R., Wong, L. Y., Brulois, K. F., et al. (2010). Epigenetic analysis of KSHV latent and lytic genomes. PLoS Pathog. 6:e1001013. doi: 10.1371/journal.ppat.1001013
159. Tsuyama, T., Tada, S., Watanabe, S., Seki, M., and Enomoto, T. (2005). Licensing for DNA replication requires a strict sequential assembly of Cdc6 and Cdt1 onto chromatin in Xenopus egg extracts. Nucleic Acids Res. 33, 765-775. doi: 10.1093/nar/gki226
160. Ueda, K., Sakakibara, S., Ohsaki, E., and Yada, K. (2006). Lack of a mechanism for faithful partition and maintenance of the KSHV genome. Virus Res. 122, 85-94. doi: 10.1016/j.virusres.2006.07.002
161. Uppal, T., Banerjee, S., Sun, Z., Verma, S. C., and Robertson, E. S. (2014). KSHV LANA-the master regulator of KSHV latency. Viruses 6, 4961-4998. doi: 10.3390/v6124961
162. Valiya Veettil, M., Dutta, D., Bottero, V., Bandyopadhyay, C., Gjyshi, O., Sharma-Walia, N., et al. (2014). Glutamate secretion and metabotropic glutamate receptor 1 expression during Kaposi's sarcoma-associated herpesvirus infection promotes cell proliferation. PLoS Pathog. 10:e1004389. doi: 10.1371/journal.ppat.1004389
163. Van Dross, R., Yao, S., Asad, S., Westlake, G., Mays, D. J., Barquero, L., et al. (2005). Constitutively active K-cyclin/cdk6 kinase in Kaposi sarcoma-associated herpesvirus-infected cells. J. Natl. Cancer Inst. 97, 656-666. doi: 10.1093/jnci/dji113
164. Verma, D., Li, D. J., Krueger, B., Renne, R., and Swaminathan, S. (2015). Identification of the physiological gene targets of the essential lytic replicative Kaposi's sarcoma-associated herpesvirus ORF57 protein. J. Virol. 89, 1688-1702. doi: 10.1128/JVI.02663-14
165. Verma, S. C., Borah, S., and Robertson, E. S. (2004). Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus up-regulates transcription of human telomerase reverse transcriptase promoter through interaction with transcription factor Sp1. J. Virol. 78, 10348-10359. doi: 10.1128/JVI.78.19.10348-10359.2004
166. Verma, S. C., Cai, Q., Kreider, E., Lu, J., and Robertson, E. S. (2013). Comprehensive analysis of LANA interacting proteins essential for viral genome tethering and persistence. PLoS ONE 8:e74662. doi: 10.1371/journal.pone.0074662
167. Verma, S. C., Choudhuri, T., Kaul, R., and Robertson, E. S. (2006). Latency-associated nuclear antigen (LANA) of Kaposi's sarcoma-associated herpesvirus interacts with origin recognition complexes at the LANA binding sequence within the terminal repeats. J. Virol. 80, 2243-2256. doi: 10.1128/JVI.80.5.2243-2256.2006
168. Verma, S. C., Choudhuri, T., and Robertson, E. S. (2007a). The minimal replicator element of the Kaposi's sarcoma-associated herpesvirus terminal repeat supports replication in a semiconservative and cell-cycle-dependent manner. J. Virol. 81, 3402-3413. doi: 10.1128/JVI.01607-06
169. Verma, S. C., Lan, K., Choudhuri, T., Cotter, M. A., and Robertson, E. S. (2007b). An autonomous replicating element within the KSHV genome. Cell Host Microbe 2, 106-118. doi: 10.1016/j.chom.2007.07.002
170. Verma, S. C., Lan, K., and Robertson, E. (2007c). Structure and function of latency-associated nuclear antigen. Curr. Top. Microbiol. Immunol. 312, 101-136. doi: 10.1007/978-3-540-34344-8_4
171. Verma, S. C., Lu, J., Cai, Q., Kosiyatrakul, S., McDowell, M. E., Schildkraut, C. L., et al. (2011). Single molecule analysis of replicated DNA reveals the usage of multiple KSHV genome regions for latent replication. PLoS Pathog. 7:e1002365. doi: 10.1371/journal.ppat.1002365
172. Waldmann, T., Scholten, I., Kappes, F., Hu, H. G., and Knippers, R. (2004). The DEK protein-an abundant and ubiquitous constituent of mammalian chromatin. Gene 343, 1-9. doi: 10.1016/j.gene.2004.08.029
173. Wang, C., Zhu, C., Wei, F., Zhang, L., Mo, X., Feng, Y., et al. (2015). Constitutive activation of Interleukin-13/STAT6 Contributes to Kaposi's sarcoma-associated Herpesvirus-Related primary effusion lymphoma cell proliferation and survival. J. Virol. 89, 10416-10426. doi: 10.1128/JVI.01525-15
174. Wang, X., He, Z., Xia, T., Li, X., Liang, D., Lin, X., et al. (2014). Latency-associated nuclear antigen of Kaposi sarcoma-associated herpesvirus promotes angiogenesis through targeting notch signaling effector Hey1. Cancer Res. 74, 2026-2037. doi: 10.1158/0008-5472.CAN-13-1467
175. Wyrick, J. J., Aparicio, J. G., Chen, T., Barnett, J. D., Jennings, E. G., Young, R. A., et al. (2001). Genome-wide distribution of ORC and MCM proteins in S. cerevisiae: high-resolution mapping of replication origins. Science 294, 2357-2360. doi: 10.1126/science.1066101
176. Xiao, B., Verma, S. C., Cai, Q., Kaul, R., Lu, J., Saha, A., et al. (2010). Bub1 and CENP-F can contribute to Kaposi's sarcoma-associated herpesvirus genome persistence by targeting LANA to kinetochores. J. Virol. 84, 9718-9732. doi: 10.1128/JVI.00713-10
177. Xie, J., Ajibade, A. O., Ye, F., Kuhne, K., and Gao, S. J. (2008). Reactivation of Kaposi's sarcoma-associated herpesvirus from latency requires MEK/ERK, JNK and p38 multiple mitogen-activated protein kinase pathways. Virology 371, 139-154. doi: 10.1016/j.virol.2007.09.040
178. Yang, Y., Groshong, J. S., Matta, H., Gopalakrishnan, R., Yi, H., and Chaudhary, P. M. (2011). Constitutive NF-kappaB activation confers interleukin 6 (IL6) independence and resistance to dexamethasone and Janus kinase inhibitor INCB018424 in murine plasmacytoma cells. J. Biol. Chem. 286, 27988-27997. doi: 10.1074/jbc. M110.213363
179. Ye, F. C., Blackbourn, D. J., Mengel, M., Xie, J. P., Qian, L. W., Greene, W., et al. (2007). Kaposi's sarcoma-associated herpesvirus promotes angiogenesis by inducing angiopoietin-2 expression via AP-1 and Ets1. J. Virol. 81, 3980-3991. doi: 10.1128/JVI.02089-06
180. Ye, F. C., Lei, X., and Gao, S. J. (2011). Mechanisms of Kaposi's Sarcoma-Associated Herpesvirus Latency and Reactivation. Adv. Virol. 2011:193860. doi: 10.1155/2011/193860
181. Ye, F.-C., Zhou, F. C., Xie, X.-P., Kang, T., Greene, W., Kuhne, K., et al. (2008). Kaposi's Sarcoma-Associated Herpesvirus latent gene vFLIP inhibits viral lytic replication through NF-κB-Mediated suppression of the AP-1 pathway: a novel mechanism of Virus control of latency. J. Virol. 82, 4235-4249. doi: 10.1128/JVI.02370-07
182. Ye, F. C., Zhou, F. C., Yoo, S. M., Xie, J. P., Browning, P. J., and Gao, S. J. (2004). Disruption of Kaposi's sarcoma-associated herpesvirus latent nuclear antigen leads to abortive episome persistence. J. Virol. 78, 11121-11129. doi: 10.1128/JVI.78.20.11121-11129.2004
183. You, J., Croyle, J. L., Nishimura, A., Ozato, K., and Howley, P. M. (2004). Interaction of the bovine papillomavirus E2 protein with Brd4 tethers the viral DNA to host mitotic chromosomes. Cell 117, 349-360. doi: 10.1016/S0092-8674(04)00402-7
184. You, J., Srinivasan, V., Denis, G. V., Harrington, W. J. Jr., Ballestas, M. E., Kaye, K. M., et al. (2006). Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with bromodomain protein Brd4 on host mitotic chromosomes. J. Virol. 80, 8909-8919. doi: 10.1128/JVI.00502-06
185. Yu, F., Harada, J. N., Brown, H. J., Deng, H., Song, M. J., Wu, T. T., et al. (2007). Systematic identification of cellular signals reactivating Kaposi sarcoma-associated herpesvirus. PLoS Pathog. 3:e44. doi: 10.1371/journal.ppat.0030044
186. Yu, Y., Black, J. B., Goldsmith, C. S., Browning, P. J., Bhalla, K., and Offermann, M. K. (1999). Induction of human herpesvirus-8 DNA replication and transcription by butyrate and TPA in BCBL-1 cells. J. Gen. Virol. 80 (Pt 1), 83-90. doi: 10.1099/0022-1317-80-1-83
187. Zagzag, D., Zhong, H., Scalzitti, J. M., Laughner, E., Simons, J. W., and Semenza, G. L. (2000). Expression of hypoxia-inducible factor 1alpha in brain tumors: association with angiogenesis, invasion, and progression. Cancer 88, 2606-2618. doi: 10.1002/1097-0142(20000601)88:11<2606::AID-CNCR25>3.0.CO;2-W
188. Zeng, Y., Zhang, X., Huang, Z., Cheng, L., Yao, S., Qin, D., et al. (2007). Intracellular Tat of human immunodeficiency virus type 1 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus: role of JAK/STAT signaling. J. Virol. 81, 2401-2417. doi: 10.1128/JVI.02024-06
189. Zhang, L., Zhu, C., Guo, Y., Wei, F., Lu, J., Qin, J., et al. (2014). Inhibition of KAP1 enhances hypoxia-induced Kaposi's sarcoma-associated herpesvirus reactivation through RBP-Jkappa. J. Virol. 88, 6873-6884. doi: 10.1128/JVI.00283-14
190. Zhong, H., De Marzo, A. M., Laughner, E., Lim, M., Hilton, D. A., Zagzag, D., et al. (1999). Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res. 59, 5830-5835.